Post-Vaccinal Encephalitis with Early Relapse after BNT162b2 (COMIRNATY) COVID-19 Vaccine: A Case Report

Post-Vaccinal Encephalitis with Early Relapse after BNT162b2 (COMIRNATY) COVID-19 Vaccine: A Case Report

We describe the case of a 72-year-old man who received the first dose of the BNT162b2 (COMIRNATY) vaccine against COVID-19 on 18 May 2021, and the second dose on 9 September 2021. One day after receiving the first dose, he cursed with malaise, headache, fever, confusion, aggressiveness, and gait alt...

Full description

Bibliographic Details
Main Authors: Albujar, M.F (Author), Alvarez, A. (Author), Araujo-Chumacero, M.M (Author), Barja, E. (Author), Canales, D. (Author), Cardenas, E. (Author), Urrunaga-Pastor, D. (Author), Vences, M.A (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
COVID-19
drug-related side effects and adverse reactions
encephalitis
SARS-CoV-2
vaccination
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items